1:00 PM ET | noon CT | 11:00 AM MT | 10:00 AM PT
Every year, we bring you an update on therapy development for FSHD. What strategies are being considered? How are different candidate drugs progressing through the process of reaching the clinic? What’s the latest on clinical trials? Nick Johnson, MD, director of the FSHD research center at Virginia Commonwealth University, will present the latest news and answer your questions.